{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:36:19Z","timestamp":1772498179673,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,11,27]],"date-time":"2013-11-27T00:00:00Z","timestamp":1385510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s10620-013-2930-4","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T11:33:11Z","timestamp":1385465591000},"page":"1001-1011","source":"Crossref","is-referenced-by-count":54,"title":["Colonic Mucosal Immune Activity in Irritable Bowel Syndrome: Comparison with Healthy Controls and Patients with Ulcerative Colitis"],"prefix":"10.1007","volume":"59","author":[{"given":"Ji Yong","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Hun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Hwan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Woong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui Young","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungbong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sae Kyung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,27]]},"reference":[{"key":"2930_CR1","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"GF Longstreth","year":"2006","unstructured":"Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480\u20131491.","journal-title":"Gastroenterology"},{"key":"2930_CR2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ajg.2008.94","volume":"104","author":"C Cremon","year":"2009","unstructured":"Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009;104:392\u2013400.","journal-title":"Am J Gastroenterol"},{"key":"2930_CR3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","volume":"126","author":"G Barbara","year":"2004","unstructured":"Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693\u2013702.","journal-title":"Gastroenterology"},{"key":"2930_CR4","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/gut.2003.021154","volume":"53","author":"LH Wang","year":"2004","unstructured":"Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut. 2004;53:1096\u20131101.","journal-title":"Gut"},{"key":"2930_CR5","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1572-0241.2003.07542.x","volume":"98","author":"SP Dunlop","year":"2003","unstructured":"Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol. 2003;98:1578\u20131583.","journal-title":"Am J Gastroenterol"},{"key":"2930_CR6","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/gut.47.6.804","volume":"47","author":"RC Spiller","year":"2000","unstructured":"Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804\u2013811.","journal-title":"Gut"},{"key":"2930_CR7","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1440-1746.2008.05574.x","volume":"23","author":"KJ Lee","year":"2008","unstructured":"Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol. 2008;23:1689\u20131694.","journal-title":"J Gastroenterol Hepatol"},{"key":"2930_CR8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2982.2005.00719.x","volume":"17","author":"J Wheatcroft","year":"2005","unstructured":"Wheatcroft J, Wakelin D, Smith A, Mahoney CR, Mawe G, Spiller R. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil. 2005;17:863\u2013870.","journal-title":"Neurogastroenterol Motil"},{"key":"2930_CR9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1440-1746.2005.04143.x","volume":"21","author":"JH Park","year":"2006","unstructured":"Park JH, Rhee PL, Kim HS, et al. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J Gastroenterol Hepatol. 2006;21:71\u201378.","journal-title":"J Gastroenterol Hepatol"},{"key":"2930_CR10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.gastro.2006.11.039","volume":"132","author":"G Barbara","year":"2007","unstructured":"Barbara G, Wang B, Stanghellini V, et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology. 2007;132:26\u201337.","journal-title":"Gastroenterology"},{"key":"2930_CR11","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1172\/JCI29255","volume":"117","author":"N Cenac","year":"2007","unstructured":"Cenac N, Andrews CN, Holzhausen M, et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest. 2007;117:636\u2013647.","journal-title":"J Clin Invest"},{"key":"2930_CR12","doi-asserted-by":"crossref","first-page":"i41","DOI":"10.1136\/gut.51.suppl_1.i41","volume":"51","author":"G Barbara","year":"2002","unstructured":"Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome? Gut. 2002;51:i41\u2013i44.","journal-title":"Gut"},{"key":"2930_CR13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cgh.2006.03.003","volume":"4","author":"T Burgmann","year":"2006","unstructured":"Burgmann T, Clara I, Graff L, et al. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis\u2014how much is irritable bowel syndrome? Clin Gastroenterol Hepatol. 2006;4:614\u2013620.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2930_CR14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ibd.20059","volume":"13","author":"D Limsui","year":"2007","unstructured":"Limsui D, Pardi DS, Camilleri M, et al. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis. 2007;13:175\u2013181.","journal-title":"Inflamm Bowel Dis"},{"key":"2930_CR15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1572-0241.2002.05475.x","volume":"97","author":"M Simren","year":"2002","unstructured":"Simren M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Bjornsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002;97:389\u2013396.","journal-title":"Am J Gastroenterol"},{"key":"2930_CR16","first-page":"145","volume":"53","author":"CH Choi","year":"2009","unstructured":"Choi CH, Jung SA, Lee BI, Lee KM, Kim JS, Han DS. Diagnostic guideline of ulcerative colitis. Korean J Gastroenterol. 2009;53:145\u2013160.","journal-title":"Korean J Gastroenterol"},{"key":"2930_CR17","first-page":"1371","volume":"99","author":"A Kornbluth","year":"2004","unstructured":"Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology. Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371\u20131385.","journal-title":"Practice Parameters Committee. Am J Gastroenterol"},{"key":"2930_CR18","doi-asserted-by":"crossref","unstructured":"Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501-523; quiz 524.","DOI":"10.1038\/ajg.2009.727"},{"key":"2930_CR19","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625\u20131629.","journal-title":"N Engl J Med"},{"key":"2930_CR20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2004.11.050","volume":"128","author":"L O\u2019Mahony","year":"2005","unstructured":"O\u2019Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128:541\u2013551.","journal-title":"Gastroenterology"},{"key":"2930_CR21","doi-asserted-by":"crossref","unstructured":"Veldhuyzen van Zanten SJ, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR. Design of treatment trials for functional gastrointestinal disorders. Gut. 1999;45:II69-77.","DOI":"10.1136\/gut.45.2008.ii69"},{"key":"2930_CR22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr. Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473\u2013483.","journal-title":"Med Care"},{"key":"2930_CR23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1023\/A:1018831127942","volume":"43","author":"DL Patrick","year":"1998","unstructured":"Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 1998;43:400\u2013411.","journal-title":"Dig Dis Sci"},{"key":"2930_CR24","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s10620-006-9084-6","volume":"51","author":"JM Park","year":"2006","unstructured":"Park JM, Choi MG, Oh JH, et al. Cross-cultural validation of Irritable Bowel Syndrome Quality of Life in Korea. Dig Dis Sci. 2006;51:1478\u20131484.","journal-title":"Dig Dis Sci"},{"key":"2930_CR25","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ajg.2009.116","volume":"104","author":"L Ohman","year":"2009","unstructured":"Ohman L, Isaksson S, Lindmark AC, et al. T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol. 2009;104:1205\u20131212.","journal-title":"Am J Gastroenterol"},{"key":"2930_CR26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ajg.2011.315","volume":"107","author":"M Vivinus-Nebot","year":"2012","unstructured":"Vivinus-Nebot M, Dainese R, Anty R, et al. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells. Am J Gastroenterol. 2012;107:75\u201381.","journal-title":"Am J Gastroenterol"},{"key":"2930_CR27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/00365521.2012.666672","volume":"47","author":"AP Silva De","year":"2012","unstructured":"De Silva AP, Nandasiri SD, Hewavisenthi J, et al. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting. Scand J Gastroenterol. 2012;47:619\u2013624.","journal-title":"Scand J Gastroenterol"},{"key":"2930_CR28","doi-asserted-by":"crossref","first-page":"1102-e1566","DOI":"10.1111\/j.1365-2982.2012.01990.x","volume":"24","author":"M Bashashati","year":"2012","unstructured":"Bashashati M, Rezaei N, Bashashati H, et al. Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil. 2012;24:1102-e1566.","journal-title":"Neurogastroenterol Motil"},{"key":"2930_CR29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1440-1746.1998.tb00736.x","volume":"13","author":"K Yamagata","year":"1998","unstructured":"Yamagata K, Tanaka M, Kudo H. A quantitative immunohistochemical evaluation of inflammatory cells at the affected and unaffected sites of inflammatory bowel disease. J Gastroenterol Hepatol. 1998;13:801\u2013808.","journal-title":"J Gastroenterol Hepatol"},{"key":"2930_CR30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0016-5085(91)90024-F","volume":"101","author":"RG Quist","year":"1991","unstructured":"Quist RG, Ton-Nu HT, Lillienau J, Hofmann AF, Barrett KE. Activation of mast cells by bile acids. Gastroenterology. 1991;101:446\u2013456.","journal-title":"Gastroenterology"},{"key":"2930_CR31","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1440-1746.1998.tb00558.x","volume":"13","author":"XY Gui","year":"1998","unstructured":"Gui XY. Mast cells: a possible link between psychological stress, enteric infection, food allergy and gut hypersensitivity in the irritable bowel syndrome. J Gastroenterol Hepatol. 1998;13:980\u2013989.","journal-title":"J Gastroenterol Hepatol"},{"key":"2930_CR32","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3892\/mmr.2013.1320","volume":"7","author":"M El-Salhy","year":"2013","unstructured":"El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T. Low-grade inflammation in the rectum of patients with sporadic irritable bowel syndrome. Mol Med Rep. 2013;7:1081\u20131085.","journal-title":"Mol Med Rep"},{"key":"2930_CR33","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/BF01303164","volume":"38","author":"AP Weston","year":"1993","unstructured":"Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci. 1993;38:1590\u20131595.","journal-title":"Dig Dis Sci"},{"key":"2930_CR34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2982.2000.00221.x","volume":"12","author":"M O\u2019Sullivan","year":"2000","unstructured":"O\u2019Sullivan M, Clayton N, Breslin NP, et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil. 2000;12:449\u2013457.","journal-title":"Neurogastroenterol Motil"},{"key":"2930_CR35","first-page":"678","volume":"49","author":"Y Nishida","year":"2002","unstructured":"Nishida Y, Murase K, Isomoto H, et al. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease. Hepatogastroenterology. 2002;49:678\u2013682.","journal-title":"Hepatogastroenterology"},{"key":"2930_CR36","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3109\/00365521.2011.579156","volume":"46","author":"EA Hoboken van","year":"2011","unstructured":"van Hoboken EA, Thijssen AY, Verhaaren R, et al. Symptoms in patients with ulcerative colitis in remission are associated with visceral hypersensitivity and mast cell activity. Scand J Gastroenterol. 2011;46:981\u2013987.","journal-title":"Scand J Gastroenterol"},{"key":"2930_CR37","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2007.01.046","volume":"132","author":"T Liebregts","year":"2007","unstructured":"Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132:913\u2013920.","journal-title":"Gastroenterology"},{"key":"2930_CR38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.gastro.2005.11.033","volume":"130","author":"TG Dinan","year":"2006","unstructured":"Dinan TG, Quigley EM, Ahmed SM, et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology. 2006;130:304\u2013311.","journal-title":"Gastroenterology"},{"key":"2930_CR39","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.33579","volume":"122","author":"VS Chadwick","year":"2002","unstructured":"Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002;122:1778\u20131783.","journal-title":"Gastroenterology"},{"key":"2930_CR40","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2003.09.028","volume":"125","author":"SP Dunlop","year":"2003","unstructured":"Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003;125:1651\u20131659.","journal-title":"Gastroenterology"},{"key":"2930_CR41","first-page":"315","volume":"31","author":"F Arevalo","year":"2011","unstructured":"Arevalo F, Aragon V, Montes P, Guzman E, Monge E. Increase of intraepithelial lymphocytes in patients with irritable bowel syndrome. Rev Gastroenterol Peru. 2011;31:315\u2013318.","journal-title":"Rev Gastroenterol Peru"},{"key":"2930_CR42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.prp.2012.06.005","volume":"208","author":"E Reichman-Warmusz","year":"2012","unstructured":"Reichman-Warmusz E, Kurek J, Gabriel A, et al. Tissue hemostasis and chronic inflammation in colon biopsies of patients with inflammatory bowel disease. Pathol Res Pract. 2012;208:553\u2013556.","journal-title":"Pathol Res Pract"},{"key":"2930_CR43","doi-asserted-by":"crossref","unstructured":"Dai SX, Wu G, Zou Y, et al. Balance of CD8(+)CD28 (+)\/CD8 (+)CD28 (\u2212) T lymphocytes is vital for patients with ulcerative colitis. Dig Dis Sci. 2013;58:88\u201396.","DOI":"10.1007\/s10620-012-2327-9"},{"key":"2930_CR44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5009\/gnl.2011.5.1.29","volume":"5","author":"HS Cho","year":"2011","unstructured":"Cho HS, Park JM, Lim CH, et al. Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut Liver. 2011;5:29\u201336.","journal-title":"Gut Liver"},{"key":"2930_CR45","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1053\/gast.2000.16484","volume":"119","author":"IM Gralnek","year":"2000","unstructured":"Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654\u2013660.","journal-title":"Gastroenterology"},{"key":"2930_CR46","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/BF02071408","volume":"41","author":"WE Whitehead","year":"1996","unstructured":"Whitehead WE, Burnett CK, Cook EW III, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci. 1996;41:2248\u20132253.","journal-title":"Dig Dis Sci"},{"key":"2930_CR47","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/BF01538073","volume":"34","author":"DA Drossman","year":"1989","unstructured":"Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci. 1989;34:1379\u20131386.","journal-title":"Dig Dis Sci"},{"key":"2930_CR48","doi-asserted-by":"crossref","unstructured":"Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin N Am. 2005;34:235\u2013245, vi\u2013vii.","DOI":"10.1016\/j.gtc.2005.02.007"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-013-2930-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-013-2930-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-013-2930-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T03:14:46Z","timestamp":1564888486000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-013-2930-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,27]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["2930"],"URL":"https:\/\/doi.org\/10.1007\/s10620-013-2930-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,27]]}}}